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Abstract 
Background :  To find out incidence of extended 
spectrum β lactamases ( ESβLs) in  multi drug 
resistance(MDR) Salmonella typhi. 
Methods: S. typhi isolates(n=342) were collected 
from blood culture samples. Pathogens were 
identified by AP1-20 E. Susceptibility was 
determined by using Kirby-Bauer disc diffusion 
method and ESBL production by double disc 
synergy test.  
Results: First line anti typhoid drugs i.e. 
Chloramphenical, Ampicillin and 
Trimethoprim/Sulfamethoxazole showed 86, 82, 80% 
and ciprofloxacin 52% susceptibility respectively. 
Sixty eight MDR S.typhi  were collected during 2011 
and the isolates  decreased to 20  in 2012. The 
decrease was statistically significant (p < 0.001). 
Only one isolate was ESBL producer accounting (0.68 
%). 
Conclusion: Typhoid fever is endemic throughout 
the year. Withdrawal of first line anti-typhoid drugs 
resulted in re-emerging susceptibility.Maximum 
cases were during hot, humid weather and minimum 
during cold season. MDR isolation rate decreased 
due to withdrawal of first line anti typhoid drugs 
and frequent use of third generation cephalosporins. 
Susceptibility of third generation cephalosporin, 
carbapenem and gentamycin were found to be 
highly effective. 
 Key Words:  Extended-spe ct rum  β -lactamase, 
multi drug resistance, salmonella typhi.  
 
Introduction 
    Multi drug resistant Salmonella typhi (MDR S. typhi) 
is a major public health problem in tropical and sub 
tropical regions of the world. It affects both local 
populations and travelers to the endemic areas. More 
than 75% of world population is facing 90 % of global 
typhoid epidemics in developing countries.1-3 The 
disease is also a serious potential threat to the 
developed nations. In England and Wales more than 70 
% typhoid fever patients represent immigrants 
returning from Sri Lanka, India, Pakistan and 
Bangladesh. According to the World Health 
Organization more than 30 million new cases of 
typhoid fever occurred each year causing 216,000 
deaths.4,5  In Pakistan typhoid fever represents the 4th 
most common cause of death. Mortality rates ranging 
from 12 to 32 % have been recorded from Asian 
countries including Pakistan, India, Bangladesh, and 
Nepal. Incidence of typhoid fever can be curtailed with 
proper treatment, provision of clean drinking water, 
better sanitary conditions and improved hygiene. 
Disease burden is under-estimated due to limited 
availability of culture facilities and inadequate  disease 
reporting systems in the developing countries.6,7  
     Chloramphenical was first time used in 1948 for the 
treatment of typhoid fever. It reduced the duration of 
fever from weeks to days, mortality to less than 1 % 
and yielded fairly uniform clinical response all over the 
world. It remained gold standard drug of choice till 
emergence of drug resistant serotypes.8, 9  Ampicillin 
has been found to be an excellent antimicrobial since 
1961-1967 in Chloramphenical resistant infection. 
Trimethoprim / sulfamethoxazole proved to be as 
good as Ampicillin in both Chloramphenical and 
Ampicillin resistant cases.10,11  MDR S. typhi was 
isolated in 1987 from Pakistan and its incidence 
increased to over 80 % and was being successfully 
treated with ciprofloxacin till 1990s. Ceftriaxone was 
considered the drug of choice in fluoroquinolone 
resistant cases. Sporadic cases of third generation 
cephalosporin resistant S. typhi have been reported but 
the emergence of extended spectrum beta lactamase in 
MDR S. typhi constitutes a new challenge and has 
become a matter of serious concern, especially in the 
developing countries. Newly emerged resistant trait 
has further restricted the treatment options.12, 13 
 
Patients and Methods 
    Three hundred and forty two S. typhi isolates were 
collected from blood culture samples of the patients 
with pyrexia of unknown origin from Jan 2011 to Dec 
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2012 at Social Security Hospital Lahore.  One positive 
sample from each patient was included in the 
study.Blood samples were sub cultured on 
Mac.Conkey agar, Blood agar and Chocolate agar. 
Inoculated plates were incubated aerobically at 37⁰C 
for 24 hours. If no growth observed after 48 hours, sub 
cultures were repeated on 5th and 7th days of 
incubation. Identification of isolates included colonial 
morphology, gram staining, and biochemical tests 
employing AP1-20 E identification system, followed 
by serological identification of S. typhi  (Salmonella O, 
H & Vi) antigen.14 The antimicrobial susceptibility 
pattern was determined by Kirby-Bauer disc diffusion 
method in accordance with the Clinical and 
Laboratory Standard Institute (CLSI) guideline . The 
antimicrobial agents tested were Ampicillin (10mg/l), 
Chloramphenical (30mg/l), Trimethoprim (1.25mg/l), 
sulfamethoxazole (25mg/l), Ceftriaxone (30mg/l), 
cefotaxime (30mg/l) ceftazidime (30mg/l), 
ciprofloxacin (5mg/l), nalidixic acid (30mg/l) and 
others. Zone edges examined with naked eye were 
considered point of complete inhibition of growth. 
Zone of inhibition around each antibiotic disc was 
measured with the help of vernier calipers. If the 
distance between radius of zone in controlled area and 
the radius of zone in the testing area was equal to or 
less than 3mm, the test organism was considered 
sensitive while it was considered resistant if the zone 
radius measured was equal or more than 3mm. The 
isolates showed zones of inhibition (ZOI) less than 22 
mm for CAZ and less than 27 mm for CTX were also 
tested by double disc synergy test in combination with 
the co-amoxiclav (amoxicillin + clavulanic acid) for 
production of extended spectrum beta lactamase. 
Staphylococcus aureus (ATCC – 25923), Pseudomonas 
aeruginosa (ATCC – 27853), E. coli (ATCC – 25922), 
Acinetobacter baumanni (ATCC – 29212) and 
Enterococcus faecalis (ATCC – 29212) were used as 
reference strains and treated similarly for quality 
control. 
Results 
    Among total (342) S. typhi infected patients 52% 
were males. Patients were classified into three age 
groups, children (5-15 years), adults (16-60 years) and 
elders (61-85 years). Maximum number of patients was 
from children age group(Table 1). 
     Isolation of S. typhi was recorded in each month of 
the both years from Jan 2011 – Dec 2012. A decreasing 
trend was noted in overall isolation of S. typhi from 
2011 to 2012. Maximum incidence (9.8 % to 10.4 %) 
occurred during hot and humid months of June, July 
and August. Incidence decreased to minimal in winter 
season during November, December, January and 
February accounting 6.2% to 7.8 %. In rest of the 
months (March to May and in September and 
October), the incidence remained between 7.6% and 
7.7% throughout the study period (Table 2).      
Table 1.Distribution of the patients in  
different age groups 
Age group     
(years) 
Total (%) Male (%) 
Female
(%) 
Children (5-
15) 
160  (46.7) 77  (48.2) 83 
Adult (16-60) 119  (35) 41 (34.4) 78 
Elder age        
(61-85) 
63  (18.4) 31  (49.2) 32  
   Out of 342 S. typhi isolates,25.7% were MDR S. typhi. 
Among these MDR S. typhi, 68 were collected during 
2011. Isolation number of MDR S. typhi decreased to 
20 isolates in 2012. The decrease was statistically 
significant (p < 0.001). Maximum average incidence 
was seen during the months of July and August (Table 
3).  
     Significant increase in susceptibility of first- line 
anti typhoid drugs has been observed against S. typhi 
isolates. Sensitivity of Chloramphenical, Ampicillin 
and Trimethoprim / Sulfamethoxazole increased from 
46.8 %, 32.3 % and 36.4 %, respectively in 2011 to 86 %, 
82 % and 80 % during 2012.  Ciprofloxacin showed 
decline in susceptibility pattern from 2011 to 2012. 
Susceptibility of ciprofloxacin was 73.9 % in 2011 
which reduced to 47.3 % during the end of year 2012. 
Incidence of nalidixic acid resistant S. typhi increased 
from 87.5 % in 2011 to 93.3 % during 2012. 
Susceptibility of cephalosporin including Ceftriaxone 
94.6 %, cefotaxime and ceftazidime both were 95.3 % 
susceptible. From carbapenem group, imipenem and 
meropenem were the most potent antimicrobials with 
susceptibility rate of 96.6 % and 97.3 %. Second most 
effective antimicrobial group was gentamycin proved 
88 % effective against tested isolates(Table 4).    
Table 2.  Isolation of S. typhi in each month during study. 
Total 
cases 
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
192 
17 
(8.8%) 
12 
(6.2%) 
16 
(8.3%) 
13 
(6.7%) 
18 
(9.3%) 
19 
(9.8%) 
20 
(10.4%) 
19 
(9.8%) 
13 
(6.7%) 
16 
(8.3%) 
15 
(7.8%) 
14 
(7.2%) 
150 
10 
(6.6%) 
11 
(7.3%) 
12 
(8%) 
7 
(4.6%) 
14 
(9.3%) 
16 
(10.6%) 
17 
(11.3%) 
18 
(12%) 
14 
(9.3%) 
11 
(7.3%) 
10 
(6.6%) 
10 
(6.6%) 
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Table 3 Isolation rate of MDR S. typhi 
Year 
No. of MDR 
isolates 
%age p.value 
2011 68 / 192 77.2 % <0.001 
2012 20 / 150 22.8 %  
     
Table 4. Susceptibility pattern of Salmonella typhi 
 
2011     (n=192) 2012    (n=150) 
No(%) No(%) 
Chloramphenical 
S * 90(46.8) 129(86) 
R ** 102(53.1) 21(14) 
Ampicillin 
S  60(32.3) 123(82) 
R   130(67.7) 27(18) 
Trimethoprim/ 
Sulfamethoxazole 
S 70(36.4) 30(20) 
R 122(63.5) 30(20) 
 Ciprofloxacin 
S 142(73.9) 71(47.3) 
R 50(26.1) 79(52.7) 
Nalidixic Acid 
S 24(12.5) 10(6.7) 
R 168(87.5) 140(93.3) 
Ceftriaxone
  
S 185(96.3) 142(94.6) 
R 7(3.7) 8(5.4) 
Cefotaxime 
S 183(95.3) 143(95.3) 
R 9(4.7) 7(4.7) 
Ceftazidime 
S 184(95.8) 143(95.3) 
R  8(4.2) 7(4.7) 
Sparfloxacin 
S 185(96.3) 143(95.3) 
R 7(3.7) 7(4.7) 
Gentamycin  
S 170(88.5) 132(88) 
R 22(11.5) 18(12) 
Imipenem 
S 187(97.3) 145(96.6) 
R 5(2.7) 5(3.4) 
Meropenem 
S 188(97.9) 146(97.3) 
R  4(2.1) 4(2.7) 
*S:Susceptible; **R=resistant 
 
Among 88 - MDR S. typhi isolates 06 (6.8%) isolates 
showed reduced susceptibility to cephalosporin on 
Muller – Hinton agar using modified Kirby - Bauer 
disc diffusion method. These isolates were further 
tested for ESBL production using double disc synergy 
test. Out of 06 only one isolate (1.1%) found as ESBL 
producer in the present study. 
 
Discussion 
     Incidence of typhoid fever has no gender 
influence.15-17 In present study maximum patients 
belonged to pediatric age group (46.7%). These 
findings are comparable with results reported from 
India, and Sri Lanka. 18-19   Maximum cases were 
isolated during hot, humid weather and minimum 
during cold season. Impact of climate has been 
assumed that hot rainy season and humid 
environmental conditions enhance the prevalence of 
typhoid fever. Seasonal variations are due to less 
chances of the S. typhi rapid growth rates and less 
consumption of water and other contaminated fluids 
in colder months. There is no evidence to suggest that 
the incidence of enteric fever has gone down because 
factors responsible for endemicity of enteric fever have 
not changed in the society.20 
       Significant decrease in isolation rate of S.typhi is 
indicative of progress in general public hygienic 
conditions as well as health education. The decrease in 
the isolation rate of the organism does not necessarily 
reflect a decrease in the prevalence of the disease. 
Antibiotics are easily available to people without 
prescription so incidence is under- reported.19, 20 
     Isolation of MDR S. typhi reduced from 68 to only 
20 cases. The result is in agreement with the findings 
of Wafsy and Mills who reported declining trend in 
isolation of MDR S. typhi. Decreased isolation might 
have occurred due to with-drawal of first line anti 
typhoid drugs as empirical therapy. Higher incidence 
is attributable to widespread use of first line anti 
typhoid drugs as empirical therapy. Results of present 
study reflects improvement in general health concern, 
personal and domestic hygiene, relatively better 
sanitary conditions, concern over quality of drinking 
water and food etc. Frequent use of third generation 
cephalosporin has also contributed towards the 
decrease in isolations of MDR S. typhi.21, 22 
       Susceptibility of first line anti-typhoid drugs 
increased while that of quinolone group decreased. 
Third generation cephalosporin, carbapenem and 
gentamycin were found to be highly effective. Mateen 
reported that only 2.5% to 15% of the isolates did not 
respond to ciprofloxacin while 3% to 7% of the isolates 
did not respond to cephalosporin.23 
      In present study, 53% isolates were resistant to 
ciprofloxacin suggesting efficacy of the drug being 
compromised. This reflects wide spread use or misuse 
of ciprofloxacin. Self-medication, low dose, shorter 
therapy and more frequently prescribed nature might 
have been contributing factors. Doughar and 
Madhulika reported excellent sensitivity of first line 
anti typhoid drugs with less than 1% resistance. Third 
generation cephalosporin has been found very 
effective. Ceftriaxone was reported to be 100% 
effective by many researchers. Haque detected 
resistance against third generation cephalosporin in 
3% isolates.24-26 
       Only one out of 6 MDR S. typhi found ESBL 
producer which is comparable with studies conducted 
at Canada, Poland, England, and France, reported up 
to 3% ESBL production in MDR S. typhi isolates. In 
India 3 – 8 % and from Latin America 2.8 % ESBL 
production has been reported in MDR S. typhi. 
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Currently emerged ESBL production in MDR S. typhi 
has constituted a new challenge for physicians treating 
enteric fever, especially in developing countries where 
typhoid is endemic through out  the year.27  
 
Conclusions 
    1. Typhoid fever is endemic throughout the year in 
Pakistan. 
     2.  Withdrawal of first line anti-typhoid drugs 
resulted in loss of R-plasmid and re-emerging 
susceptibility of these drugs. 
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